The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Tardive dyskinesia: are first signs reversible?
Abstract
Although tardive dyskinesia, a serious and sometimes irreversible side effect of antipsychotic drug use, is becoming increasingly common, there is still considerable confusion concerning the course of the syndrome. The authors observed 12 psychiatric patients with tardive dyskinesia from the inception of the syndrome. They found that first symptoms rarely persisted if antipsychotics were discontinued and concluded that the length of time symptoms have persisted prior to drug discontinuation, not age at onset, may be the major variable determining reversibility of the syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is likely to be considerable interindividual variability in this process, with patients able to tolerate greatly varying rates of reduction: given the data on time for TD to resolve, some long-term treated patients may need longer periods, and some first-episode patients or those treated for briefer periods may tolerate shorter tapering periods.75,76,78,101”
From A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (2021) · cites this paper as [101]
Citations
Cites
Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250081011 · Cited by 140
A Study of Facial Dyskinesia in a Mental Hospital Population
Brandon, S., McClelland, H. A., & Protheroe, C. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.118.543.171 · Cited by 138
Treatment of Tardive Dyskinesia
Kazamatsuri, H. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250086012 · Cited by 109
Extrapyramidal Disorders After Prolonged Phenothiazine Therapy
Kennedy, P. F., Hershon, H. I., & McGuire, R. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.118.546.509 · Cited by 98
Choline for Tardive Dyskinesia
Davis, K. L., Berger, P. A., & Hollister, L. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507172930317 · Cited by 89
HL-A Antigens and Antibody Response after Influenza a Vaccination
Spencer, M. J., Cherry, J. D., & Terasaki, P. I. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601012940104 · Cited by 85
Neurological Syndromes Associated With Antipsychotic Drug Use
Freedman, D. X. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750340009001 · Cited by 84
Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia
Klawans, H. L., & McKendall, R. R. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90087-6 · Cited by 71
Tardive Dyskinesia and Drug Therapy in Geriatric Patients
Crane, G. E. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760090055009 · Cited by 59
Axelrod, J. (1974) · Scientific American · doi:10.1038/scientificamerican0674-58 · Cited by 59
Flagged first, then by citations
Research works printed but not linked: 2
- Klawans, 1973, The Pharmacology of Extrapyramidal Movement Disorders. Monographs in Neural Sciences, vol 2. 5 Karger
- Cole JO, 1975, Dcc
Cited by
Sorted by citations
Items 101–114 of 114
Gelenberg, A. J., & Keith, S. J. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5877-4_4 · Cited by 1
What's new in the psychopharmacology of schizophrenia.
Rifkin, A. E., & Quitkin, F. M. (1978) · PubMed Central · Cited by 1
Discinesia tardía: Efecto adverso de la terapia con neurolépticos.
Bermejo, F., Quijano, T. D. S., Calandre, L., & Varela, M. (1982) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Clinical Aspects of Tardive Dyskinesia
Gárdos, G., & Cole, J. O. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5038-5_10 · Cited by 1
CNS Dopamine Receptors: Effect of Prolyl-Leucyl-Glycinamide and Solubilization
Mishra, R. K. (1984) · Nutrition and Health · doi:10.1177/026010618400300306 · Cited by 1
Drug Therapy of Aggressive Behaviors Accompanying Dementia
Gardner, M. E. (1995) · Journal of Pharmacy Practice · doi:10.1177/089719009500800503 · Cited by 1
LECITHIN TREATMENT FOR TARDIVE DYSKINESIA: A CLINICAL EVALUATION
Price, L. A. (1982) · University of North Texas Digital Library (University of North Texas) · Cited by 1
Clinical Aspects of Tardive Dyskinesia Epidemiology, Natural History, and Management
Gárdos, G., & Cole, J. O. (1986) · Cited by 1
tardive dyskinesia and changing concepts of antipsychotic drug use: a nursing prospective
Doller, J. C. (1977) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-19771101-04 · Cited by 1
(1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb05454.x · Cited by 1
Johnson, D. A. W. (1978) · Scottish Medical Journal · doi:10.1177/003693307802300307 · Cited by 1
“230 ing the course of the syndrome but the first symptoms are often reversible if the drugs are discontinued promptly (Quitkin et al., 1977).”
"Methodological issues in psychopharmacological research: Chlorpromazine—A case in point": Comment.
Smith, J. M. (1977) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1977.tb01261.x
Johnson, D. A. W. (1978) · PubMed
Portnoi, V. A., & Johnson, J. E. (1982) · Geriatric Nursing · doi:10.1016/s0197-4572(82)80078-5
Metadata
- Authors
- Quitkin, F. M., Rifkin, A. E., Gochfeld, L., & Klein, D. F.
- Venue
- American Journal of Psychiatry
- Published
- 1977-01-01
- Volume
- 134
- Issue
- 1
- Pages
- 84-87
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2414414545
- Cited by
- 114
- References
- 16
- Citations by year
- 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2014: 1
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- tardive dyskinesia, antipsychotic adverse effects, reversibility, antipsychotic discontinuation, symptom duration, age of onset, psychiatric patients
- MeSH terms
- Adult, Chlorpromazine, Dyskinesia, Drug-Induced, Female, Fluphenazine, Haloperidol, Humans, Male, Middle Aged, Prognosis, Remission, Spontaneous, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review